SIGN UP
LOG IN
S
SPRO
Spero Therapeuti
2.58
-0.08-3.01%Opening15:57 06/05 EDT
OPEN/PREV CLOSE2.640/2.660
TODAY RANGE2.520-2.685
VOL1.67M
MARKET CAP144.25M
52 WEEK RANGE0.5052-2.950
AVG VOL (3M)3.72M
% TURNOVER2.98%
TURNOVER--
P/E (TTM)-2.0137
% RANGE6.20%
EPS(TTM)-1.2812
P/E(FORWARD)-2.2435
P/B4.265
BVPS0.6049
DIVIDEND--
P/S2.936
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP109.17M
SHARES OUTSTANDING55.91M
NEXT EARNINGS08/04-08/08
FREE FLOAT42.31M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
Largest borrow rate increases among liquid names
Benzinga·5d ago
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
Benzinga·6d ago
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·05/29 10:52
3 Penny Stocks to Watch Now, 5/29/25
Benzinga·05/28 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga·05/28 17:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
NASDAQ·05/28 17:04
What's Behind The Big Stock Moves? SPRO, TIL, IMAB....
TipRanks·05/28 16:27
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
Reuters·05/28 15:56
BUZZ-U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive
Dow Jones·05/28 15:30
Spero Therapeutics Shares Soar as Trial with GSK Ends Early on Efficacy
Benzinga·05/28 15:24
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?
Benzinga·05/28 13:56
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings
TipRanks·05/28 13:13
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.